13 September 2021>: Human Study
Size of Acute Myocardial Infarction Correlates with Earlier Time of Initiation of Reperfusion Therapy with Cardiac Perfusion Scintigraphy: A National Single-Center Study
Hajdin Çitaku 1ABCDF , Ramë Miftari 23ACDEF* , David Stubljar 4ACDF , Xhevdet Krasniqi 56ADEDOI: 10.12659/MSMBR.933214
Med Sci Monit Basic Res 2021; 27:e933214
Table 1 Basic characteristics of patients at admission.
Baseline data | N=80 |
---|---|
Age (years), mean (±SD) | 60.1±10.2 |
Male (%) | 58 (72.5) |
Female, (%) | 22 (27.5) |
Hypertension, (%) | 53 (66.3) |
Diabetes mellitus, (%) | 15 (25.9) |
Dyslipidemia, (%) | 26 (32.5) |
Smoking, (%) | 39 (48.75) |
Family history of cardiovascular diseases, (%) | 23 (28.8) |
Scintigraphic infarct size, median (range) | 23.0 (1.0–72.0) |
Hemoglobin (g/L), mean (±SD) | 143.9±14.4 |
Creatinine (umol/L), median (range) | 110.0 (59.0–156.0) |
Creatine kinase-MB (IU/L), median (range) | 181.5 (9.0–1001.0) |
Creatine kinase (IU/L), median (range) | 456.5 (20.0–4966.0) |
Troponin (ng/mL), mean (±SD) | 236.8±65.76 |
Anterior infarction, (%) | 42 (52.5%) |
Culprit lesion, (%) | |
RCA | 23 (28.8%) |
LAD | 42 (52.5%) |
LCX | 15 (18.8%) |
Total ischemic time (min), median (range) | 800 (240–1040) |
Time from FMC to pPCI (min), median (range) | 65 (21–570) |
Time to infarct size assessment (days), median (range) | 5 (3–12) |